These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 33425732)

  • 1. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
    Ni J; Liu S; Qi F; Li X; Yu S; Feng J; Zheng Y
    Ann Transl Med; 2020 Mar; 8(5):209. PubMed ID: 32309356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 10. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Guo F; Hong J
    Front Genet; 2020; 11():441. PubMed ID: 32431729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
    Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
    Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
    Tan S; Spear R; Zhao J; Sun X; Wang P
    Front Genet; 2022; 13():905047. PubMed ID: 35832194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 16. IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
    Peng S; Wang G; Cheng Z; Guo Z
    Int J Gen Med; 2021; 14():4381-4393. PubMed ID: 34413671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 19. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.